Eric Segal, MD
Neurology with Special Qualifications in Child Neurology · N White Plains, NYNPI 1770736530
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $88,235 of the $132,705 with a category attached, or 66.5%. 32 manufacturers reported payments, led by Neurelis, Inc. at 43.5% of the total. Among neurology with special qualifications in child neurology clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 703 payments — averaging $188.77 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neurelis, Inc.$58K
- Greenwich Biosciences, Inc.$24K
- UCB, Inc.$15K
- Jazz Pharmaceuticals Inc.$9K
- Eisai Inc.$7K
- Aquestive Therapeutics, Inc.$5K
- plus $15K from 26 others
Across 170 payments — averaging $9432.90 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- SK Life Science, Inc.$1M
- Neurelis, Inc.$254K
- AbbVie$77K
- Eisai Inc.$72K
- UCB SA$61K
- GW Research Limited$55K
- plus $68K from 3 others
What the payments were for
- Consulting fees$19,56615%
- Speaking & faculty fees$88,23566%
- Travel & lodging$12,63610%
- Food & beverage$12,0619%
- Education$2070%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neurelis, Inc. | 194 | $57,672 |
| Greenwich Biosciences, Inc. | 65 | $24,052 |
| UCB, Inc. | 90 | $15,291 |
| Jazz Pharmaceuticals Inc. | 96 | $8,933 |
| Eisai Inc. | 44 | $7,219 |
| Aquestive Therapeutics, Inc. | 17 | $4,775 |
| Biocodex, Inc. | 6 | $4,301 |
| Novartis | 10 | $2,763 |
| Bristol Myers Squibb | 1 | $2,000 |
| SK Life Science, Inc. | 92 | $1,847 |
| Radius Health, Inc. | 1 | $900 |
| Neuropace, Inc. | 12 | $843 |
| Medtronic(2 entities) | 8 | $697 |
| Livanova USA, Inc. | 12 | $464 |
| Sunovion Pharmaceuticals Inc. | 11 | $153 |
| Supernus Pharmaceuticals, Inc. | 4 | $142 |
| Pfizer | 5 | $85 |
| Otter Pharmaceuticals, LLC | 5 | $83 |
| Aprecia Pharmaceuticals, LLC | 5 | $66 |
| Aucta Pharmaceuticals, Inc. | 5 | $59 |
| Biomarin Pharmaceutical Inc. | 3 | $51 |
| Mallinckrodt Enterprises LLC | 3 | $49 |
| Catalyst Pharmaceuticals, Inc. | 3 | $45 |
| Nobelpharma America, LLC | 2 | $41 |
| Immedica Pharma US, Inc. | 1 | $39 |
| Azurity Pharmaceuticals, Inc. | 2 | $31 |
| Ultragenyx Pharmaceutical Inc. | 1 | $30 |
| Zogenix Inc. | 1 | $16 |
| Acadia Pharmaceuticals Inc | 1 | $16 |
| PTC Therapeutics, Inc. | 1 | $15 |
| Upsher-smith Laboratories LLC | 1 | $15 |
| Xeris Pharmaceuticals, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VALTOCO$55,179
- Epidiolex$31,853
- Fintepla$13,890
- Fycompa$6,629
- DIACOMIT$4,237
- SYMPAZAN$2,805
- AFINITOR$2,625
- LIBERVANT$900
- Tymlos$900
- RNS System$411
- ACTIVA$341
- VNS - Sentiva$146
- RNS Neurostimulator Kit$132
- VNS Therapy$132
- XCOPRI$120
- QELBREE$100
How this compares
$132,705 in reported general payments places this provider in the 95th percentile of 161 neurology with special qualifications in child neurology providers in New York.
See all neurology with special qualifications in child neurology providers in New York →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other neurology with special qualifications in child neurology in N White Plains
- Claudia ChiribogaNew York$220K
- Kaleb YohayNew York$125K
- Heather LauNew York$103K
- Louis ManganasEast Setauket$86K
- Darryl DevivoNew York$67K
- Mary Lynn ChuNew York$66K
- Jonathan MinkRochester$54K
- Sanjeev KothareNew Hyde Park$53K
- Mohammad QasaymehAmherst$42K
- Puja PatelBronx$42K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.